Assessment of Dual Antiplatelet Therapy Versus Rivaroxaban In Atrial Fibrillation Patients Treated With Left Atrial Appendage Closure "ADRIFT"

Recruiting

Phase 2/3 Results N/A

References

Sources for Trial Information